Janus Henderson Group PLC Sangamo Therapeutics, Inc Transaction History

Janus Henderson Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $53,286 - $117,807	32,100 Added 129.8%	56,831 $100,000
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $418 - $626	-98 Reduced 0.39%	24,731 $122,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $354 - $670	108 Added 0.44%	24,829 $103,000
Q1 2022 May 16, 2022	BUY	$5.23 - $7.82 $41 - $62	8 Added 0.03%	24,721 $143,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $90,600 - $136,335	12,428 Added 101.16%	24,713 $185,000
Q3 2021 Nov 16, 2021	BUY	$9.01 - $12.01 $110,687 - $147,542	12,285 New	12,285 $111,000

118

43.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $183M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.